Related Experiment Videos
Developing rational protocols for paediatric psychopharmacological prescribing
1Harper House Children's Service, Radlett and Bloomfield Child and Adolescent Unit, Guy's Hospital, London, UK.
Insights
Child psychiatrists increasingly prescribe psychotropic medication for children, even those with developmental disorders. New protocols ensure safe, standardized prescribing and monitoring for better child outcomes.
Area of Science:
- Child and Adolescent Psychiatry
- Pediatric Pharmacology
- Clinical Psychology
Background:
- Increasing use of psychotropic medication in children by various medical professionals in the UK.
- Medication prescribed for conditions beyond hyperkinetic disorder and depression, including behavioral issues in developmental disorders and learning difficulties.
- Identified lack of robust clinical trial data and standardized protocols for pediatric psychotropic prescribing.
Purpose of the Study:
- To develop and describe a comprehensive set of protocols for prescribing psychotropic medication to children.
- To establish a standardized decision-making process for all referred children.
- To outline the guiding philosophies behind the protocol development and their benefits.
Main Methods:
- Development of detailed protocols for individual drug prescriptions.
- Inclusion of guidelines for informed consent, long-term monitoring, and school liaison.
- Implementation of a standardized decision-making pathway for all pediatric patients.
Main Results:
- A comprehensive protocol system has been developed and implemented.
- The system addresses prescribing details, consent, monitoring, and inter-agency communication.
- Standardized decision-making benefits children, families, prescribers, and schools.
Conclusions:
- The developed protocols provide a structured approach to pediatric psychotropic prescribing.
- This systematized approach supports safe and effective medication management.
- The system facilitates clinical audit, research, and collaborative care.
Abstract:
The number of child psychiatrists, paediatricians and general practitioners prescribing psychotropic medication for children in the UK is increasing. Medication is being used not just to treat children of normal intelligence with hyperkinetic disorder or depression, but also to modify behavioural problems in children with developmental disorders and severe learning difficulties. Literature reviews highlight the lack of robust randomized controlled drug trials on which to base clinical practice and the authors have found no appropriate existing protocols to help develop a systematized approach. Against such a background the authors have developed a comprehensive set of protocols covering prescribing details for individual drugs, and also addressing issues such as informed consent, long-term monitoring and school liaison. All children referred to the authors' clinics go through a standardized decision-making process. This article describes both the protocols themselves and the philosophies that guided their development. The authors describe how such a system benefits the children, their families, general practitioners and schools, whilst also facilitating audit and research.